Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
Devine
Steven M
SM
Jahagirdar
Balkrishna
B
van Besien
Koen
K
D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D009503:Neutropenia / Q000517:prevention & control*; D013921:Thrombocytopenia / Q000517:prevention & control*; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation
D008558:Melphalan